A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.

[1]  P. De Grandi,et al.  Prospective randomized study of two cryopreservation policies avoiding embryo selection: the pronucleate stage leads to a higher cumulative delivery rate than the early cleavage stage. , 2000, Fertility and sterility.

[2]  P. Vandekerckhove,et al.  Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. , 1996, The Cochrane database of systematic reviews.

[3]  R. Homburg,et al.  Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. , 1999, Human reproduction update.

[4]  S. Daya,et al.  Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. , 1999, Human reproduction.

[5]  W. Hop,et al.  The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. , 1998, The Journal of clinical endocrinology and metabolism.

[6]  G. Serour,et al.  Oocyte quality in patients with severe ovarian hyperstimulation syndrome. , 1997, Fertility and sterility.

[7]  C. Simón,et al.  Pregnancy and birth rates after oocyte donation. , 1997, Fertility and sterility.

[8]  H. Mason,et al.  Mechanisms of anovulation in polycystic ovary syndrome , 1997 .

[9]  S. Hillier.  Roles of follicle stimulating hormone and luteinizing hormone in controlled ovarian hyperstimulation. , 1996, Human reproduction.

[10]  D. Valbuena,et al.  Pregnancy: Oocyte donation in women with recurrent pregnancy loss , 1996 .

[11]  D. Valbuena,et al.  Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. , 1996, Fertility and sterility.

[12]  P. De Grandi,et al.  Aorto-subclavian thromboembolism: a rare complication associated with moderate ovarian hyperstimulation syndrome. , 1996, Human reproduction.

[13]  R. Buyalos,et al.  Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. , 1996, Fertility and sterility.

[14]  H. Out,et al.  A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. , 1995, Human reproduction.

[15]  A. Balen,et al.  Diagnosis, prevention and management of ovarian hyperstimulation syndrome , 1995, British journal of obstetrics and gynaecology.

[16]  J. Collins,et al.  Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. , 1995, Fertility and sterility.

[17]  S. L. Tan,et al.  A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. , 1993, Human reproduction.

[18]  I. Bukovsky,et al.  Overstimulated cycles under low-dose gonadotrophins in patients with polycystic ovary syndrome: characterization and management. , 1993, Human reproduction.

[19]  E. Rudak,et al.  The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.

[20]  O. Reymond,et al.  Why lose an in vitro fertilization cycle when stimulation fails? , 1990, Fertility and sterility.

[21]  J. Antoine,et al.  Results of IVF in the treatment of polycystic ovary disease. , 1988, Human reproduction.

[22]  R. Edwards,et al.  Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates. , 1987, Human reproduction.

[23]  S. Franks,et al.  Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. , 1986, British medical journal.

[24]  J. Price,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[25]  J. Yovich,et al.  Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase , 1985, British journal of obstetrics and gynaecology.